Highly pathogenic H5N1 influenza viruses have become endemic in poultry populations throughout Southeast Asia and continue to infect humans with a greater than 50% case fatality rate. So far, human-to-human transmission of these viruses has been limited. Here, we discuss the molecular features of H5N1 influenza viruses that might affect their pathogenicity, and explain the current lack of efficient human-to-human transmission. Such knowledge is critical in evaluating the pandemic risk these viruses pose.
References
1.
WrightP.F., NeumannG., KawaokaY.Orthomyxoviruses. In Fields Virology, 2007; pp. 1691–1740. Edited by KnipeD.M., HowleyP.M., GriffinD.E., LambR.A., MartinM.A., RoizmanB., & StrausS.E.. Philadelphia: Lippincott Willams & Wilkins.
2.
PaleseP., ShawM.Orthomyxoviridae: The Viruses and Their Replication. In Fields Virology, 2007; pp. 1647–1689. Edited by KnipeD.M., HowleyP.M., GriffinD.E., LambR.A., MartinM.A., RoizmanB., & StrausS.E.. Philadelphia: Lippincott Willams & Wilkins.
3.
ChenW., CalvoP.A., MalideD.A novel influenza A virus mitochondrial protein that induces cell death.Nat Med2001; 7: 1306–1312.
4.
BeareA.S., WebsterR.G.Replication of avian influenza viruses in humans.Arch Virol1991; 119: 37–42.
5.
SubbaraoK., KlimovA., KatzJ.Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.Science1998; 279: 393–396.
6.
ClaasE.C., OsterhausA.D., Van BeekR.Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.Lancet1998; 351: 472–477.
7.
ClaasE.C., de JongJ.C., Van BeekR.Human influenza virus A/HongKong/156/97 (H5N1) infection.Vaccine1998; 16: 977–978.
ChenH., LiY., LiZ.Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China.J Virol2006; 80: 5976–5983.
KandunI.N., WibisonoH., SedyaningsihE.R.Three Indonesian clusters of H5N1 virus infection in 2005.N Engl J Med2006; 355: 2186–2194.
12.
OlsenS.J., UngchusakK., SovannL.Family clustering of avian influenza A (H5N1).Emerg Infect Dis2005; 11: 1799–1801.
13.
UngchusakK., AuewarakulP., DowellS.F.Probable person-to-person transmission of avian influenza A (H5N1).N Engl J Med2005; 352: 333–340.
14.
MainesT.R., LuX.H., ErbS.M.Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.J Virol2005; 79: 11788–11800.
15.
ChenH., DengG., LiZ.The evolution of H5N1 influenza viruses in ducks in southern China.Proc Natl Acad Sci U S A2004; 101: 10452–10457.
16.
de JongM.D., BachV.C., PhanT.Q.Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma.N Engl J Med2005; 352: 686–691.
17.
BaumL.G., PaulsonJ.C.Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity.Acta Histochem Suppl1990; 40: 35–38.
18.
CouceiroJ.N., PaulsonJ.C., BaumL.G.Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity.Virus Res1993; 29: 155–165.
19.
ConnorR.J., KawaokaY., WebsterR.G.Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.Virology1994; 205: 17–23.
20.
RogersG.N., PaulsonJ.C.Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.Virology1983; 127: 361–373.
21.
RogersG.N., D'SouzaB.L.Receptor binding properties of human and animal H1 influenza virus isolates.Virology1989; 173: 317–322.
MatrosovichM., ZhouN., KawaokaY.The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.J Virol1999; 73: 1146–1155.
24.
MatrosovichM.N., MatrosovichT.Y., GrayT.Human and avian influenza viruses target different cell types in cultures of human airway epithelium.Proc Natl Acad Sci U S A2004; 101: 4620–4624.
25.
ShinyaK., EbinaM., YamadaS.Avian flu: influenza virus receptors in the human airway.Nature2006; 440: 435–436.
26.
van RielD., MunsterV.J., deW.E.H5N1 virus attachment to lower respiratory tract.Science2006; 312: 399.
27.
NichollsJ.M., ChanM.C., ChanW.Y.Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract.Nat Med2007; 13: 147–149.
28.
de JongM.D., SimmonsC.P., ThanhT.T.Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.Nat Med2006; 12: 1203–1207.
29.
MatrosovichM., TuzikovA., BovinN.Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.J Virol2000; 74: 8502–8512.
30.
NaeveC.W., HinshawV.S., WebsterR.G.Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus.J Virol1984; 51: 567–569.
31.
GamblinS.J., HaireL.F., RussellR.J.The structure and receptor binding properties of the 1918 influenza hemagglutinin.Science2004; 303: 1838–1842.
32.
KobasaD., TakadaA., ShinyaK.Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.Nature2004; 431: 703–707.
33.
StevensJ., CorperA.L., BaslerC.F.Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.Science2004; 303: 1866–1870.
34.
TumpeyT.M., MainesT.R., VanH.N.A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission.Science2007; 315: 655–659.
35.
GambaryanA., TuzikovA., PazyninaG.Evolution of the receptor binding phenotype of influenza A (H5) viruses.Virology2006; 344: 432–438.
36.
StevensJ., BlixtO., TumpeyT.M.Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus.Science2006; 312: 404–410.
37.
YamadaS., SuzukiY., SuzukiT.Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.Nature2006; 444: 378–382.
38.
HorimotoT., KawaokaY.Pandemic threat posed by avian influenza A viruses.Clin Microbiol Rev2001; 14: 129–149.
WebsterR.G., RottR.Influenza virus A pathogenicity: the pivotal role of hemagglutinin.Cell1987; 50: 665–666.
41.
BoschF.X., OrlichM., KlenkH.D.The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses.Virology1979; 95: 197–207.
42.
BoschF.X., GartenW., KlenkH.D.Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses.Virology1981; 113: 725–735.
43.
KawaokaY., NaeveC.W., WebsterR.G.Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?Virology1984; 139: 303–316.
44.
GarciaM., CrawfordJ.M., LatimerJ.W.Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico.J Gen Virol1996; 77 Part 7: 1493–1504.
45.
BanksJ., SpeidelE.S., MooreE.Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy.Arch Virol2001; 146: 963–973.
46.
SuarezD.L., SenneD.A., BanksJ.Recombination resulting in virulence shift in avian influenza outbreak, Chile.Emerg Infect Dis2004; 10: 693–699.
47.
PasickJ., HandelK., RobinsonJ.Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia.J Gen Virol2005; 86: 727–731.
48.
KeawcharoenJ., AmonsinA., OraveerakulK.Characterization of the hemagglutinin and neuraminidase genes of recent influenza virus isolates from different avian species in Thailand.Acta Virol2005; 49: 277–280.
49.
ShortridgeK.F., ZhouN.N., GuanY.Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.Virology1998; 252: 331–342.
50.
BenderC., HallH., HuangJ.Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997–1998.Virology1999; 254: 115–123.
51.
MatrosovichM.N., KraussS., WebsterR.G.H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity.Virology2001; 281: 156–162.
52.
ShinyaK., HattaM., YamadaS.Characterization of a human H5N1 influenza A virus isolated in 2003.J Virol2005; 79: 9926–9932.
53.
AlmondJ.W.A single gene determines the host range of influenza virus.Nature1977; 270: 617–618.
54.
ClementsM.L., SubbaraoE.K., FriesL.F.Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers.J Clin Microbiol1992; 30: 655–662.
55.
SubbaraoE.K., LondonW., MurphyB.R.A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.J Virol1993; 67: 1761–1764.
56.
HattaM., GaoP., HalfmannP.Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.Science2001; 293: 1840–1842.
57.
LiK.S., GuanY., WangJ.Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.Nature2004; 430: 209–213.
58.
PuthavathanaP., AuewarakulP., CharoenyingP.C.Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.J Gen Virol2005; 86: 423–433.
59.
SmithG.J., NaiposposT.S., NguyenT.D.Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.Virology2006; 350: 258–268.
60.
AmonsinA., PayungpornS., TheamboonlersA.Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand.Virology2006; 344: 480–491.
61.
FouchierR.A., SchneebergerP.M., RozendaalF.W.Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.Proc Natl Acad Sci U S A2004; 101: 1356–1361.
62.
MaseM., TanimuraN., ImadaT.Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice.J Gen Virol2006; 87: 3655–3659.
63.
ZhouJ.Y., ShenH.G., ChenH.X.Characterization of a highly pathogenic H5N1 influenza virus derived from bar-headed geese in China.J Gen Virol2006; 87: 1823–1833.
64.
ShinyaK., HammS., HattaM.PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice.Virology2004; 320: 258–266.
65.
Crescenzo-ChaigneB., NaffakhN., van der WerfS.Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo.Virology1999; 265: 342–353.
66.
MassinP., van der WerfS., NaffakhN.Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses.J Virol2001; 75: 5398–5404.
67.
NaffakhN., MassinP., EscriouN.Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses.J Gen Virol2000; 5: 1283–1291.
68.
LiZ., ChenH., JiaoP.Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model.J Virol2005; 79: 12058–12064.
69.
GabrielG., DauberB., WolffT.The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host.Proc Natl Acad Sci U S A2005; 102: 18590–18595.
70.
SalomonR., FranksJ., GovorkovaE.A.The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.J Exp Med2006; 203: 689–697.
71.
ButlerD.Alarms ring over bird flu mutations.Nature2006; 439: 248–249.
72.
PeirisJ.S., YuW.C., LeungC.W.Re-emergence of fatal human influenza A subtype H5N1 disease.Lancet2004; 363: 617–619.
73.
ToK.F., ChanP.K., ChanK.F.Pathology of fatal human infection associated with avian influenza A H5N1 virus.J Med Virol2001; 63: 242–246.
74.
ZhouJ., LawH.K., CheungC.Y.Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses.J Infect Dis2006; 194: 61–70.
75.
GuanY., PoonL.L., CheungC.Y.H5N1 influenza: a protean pandemic threat.Proc Natl Acad Sci U S A2004; 101: 8156–8161.
76.
CheungC.Y., PoonL.L., LauA.S.Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?Lancet2002; 360: 1831–1837.
77.
ChanM.C., CheungC.Y., ChuiW.H.Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells.Respir Res2005; 6: 135.
78.
ZhouJ., LawH.K., CheungC.Y.Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages.J Infect Dis2006; 193: 945–953.
79.
LeeD.C., CheungC.Y., LawA.H.p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1.J Virol2005; 79: 10147–10154.
SeoS.H., HoffmannE., WebsterR.G.The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses.Virus Res2004; 103: 107–113.
82.
NemeroffM.E., BarabinoS.M., LiY.Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3’ end formation of cellular pre-mRNAs.Mol Cell1998; 1: 991–1000.
83.
TwuK.Y., NoahD.L., RaoP.The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.J Virol2006; 80: 3957–3965.
84.
ChenZ., LiY., KrugR.M.Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3’-end processing machinery.EMBO J1999; 18: 2273–2283.
85.
Garcia-SastreA.Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses.Virology2001; 279: 375–384.
86.
Garcia-SastreA., EgorovA., MatassovD.Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.Virology1998; 252: 324–330.
87.
Garcia-SastreA., DurbinR.K., ZhengH.The role of interferon in influenza virus tissue tropism.J Virol1998; 72: 8550–8558.
88.
KatzeM.G., HeY., GaleM.Viruses and interferon: A fight for supremacy.Nat Rev Immunol2002; 2: 675–687.
89.
KrugR.M., YuanW., NoahD.L.Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.Virology2003; 309: 181–189.
90.
LudwigS., WangX., EhrhardtC.The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.J Virol2002; 76: 11166–11171.
91.
TalonJ., HorvathC.M., PolleyR.Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.J Virol2000; 74: 7989–7996.
92.
WangX., LiM., ZhengH.Influenza A virus NS1 protein prevents activation of NF-κB and induction of α/β interferon.J Virol2000; 74: 11566–11573.
93.
DonelanN.R., BaslerC.F., Garcia-SastreA.A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of P interferon and is attenuated in mice.J Virol2003; 77: 13257–13266.
94.
FerkoB., StasakovaJ., RomanovaJ.Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.J Virol2004; 78: 13037–13045.
95.
BergmannM., Garcia-SastreA., CarneroE.Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.J Virol2000; 74: 6203–6206.
96.
HatadaE., SaitoS., FukudaR.Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.J Virol1999; 73: 2425–2433.
97.
LuY., WambachM., KatzeM.G.Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor.Virology1995; 214: 222–228.
98.
LiS., MinJ.Y., KrugR.M.Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.Virology2006; 349: 13–21.
99.
TanS.L., KatzeM.G.Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase.J Interferon Cytokine Res1998; 18: 757–766.
100.
MinJ.Y., KrugR.M.The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'–5’ oligo (A) synthetase/RNase L pathway.Proc Natl Acad Sci U S A2006; 103: 7100–7105.
101.
Fernandez-SesmaA., MarukianS., EbersoleB.J.Influenza virus evades innate and adaptive immunity via the NS1 protein.J Virol2006; 80: 6295–6304.
102.
YuenK.Y., ChanP.K., PeirisM.Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.Lancet1998; 351: 467–471.
103.
LipatovA.S., AndreanskyS., WebbyR.J.Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses.J Gen Virol2005; 86: 1121–1130.
104.
LiZ., JiangY., JiaoP.The NS1 gene contributes to the virulence of H5N1 avian influenza viruses.J Virol2006; 80: 11115–11123.
ShawM., CooperL., XuX.Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans.J Med Virol2002; 66: 107–114.
108.
ChenG.W., ChangS.C., MokC.K.Genomic signatures of human versus avian influenza A viruses.Emerg Infect Dis2006; 12: 1353–1360.
